Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
MBRX
#4445
Moleculin Biotech, Inc.
2.040
0
USD
0.00%
Sektor:
Gesundheitswesen
Basis:
USD
Gewinnwährung:
USD
Tagesspanne
Jahresspanne
Tagesänderung
0.00%
Monatliche Änderung
-35.24%
6 month change
-35.24%
Jahresänderung
-35.24%
Vorheriger Schlusskurs
2.040
0
Open
2.020
0
Bid
2.040
0
Ask
2.043
0
Low
2.005
0
High
2.110
0
Volumen
83
Märkte
Aktien
Gesundheitswesen
MBRX
Open full chart
Financials
Overview
Finanzbericht
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
120.08 K
560.02 K
565.1 K
1.21 M
2.04 M
—
Valuation ratios
Enterprise value
-9.06 M
-3.33 M
-7.17 M
-7.19 M
-5.62 M
-23.31 M
Price to earnings ratio
-0
-0.01
0.01
0.01
-0.01
-0.01
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-0
-0.01
-0.01
-0
-0.01
-0.03
Price to book ratio
0
0.04
0
0
0.04
0.08
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.32
0.14
0.31
0.38
1.25
2.07
Return on equity %
0.99
0.38
153.24
1.14
0.94
155.71
Return on invested capital %
241.54
226
203.14
189.17
189.11
807.42
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.08
0.97
1.35
1.15
1.39
4.86
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
41.15
36.91
12.21
8.99
4.84
62.95
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
63.3
31.06
20.64
12.17
4.49
68.37
Net current asset value per share
78.12
37.71
24.99
14.61
5.28
82.6
Tangible book value per share
-24.7
-37.53
-29.71
-6.41
10.57
-63.09
Working capital per share
40.47
-1.2
6.54
1.87
1.48
8.69
Book value per share
50.34
43.41
0.11
11.54
18.04
73.1
Nachrichten
Moleculin Biotech releases CEO update on leukemia trial
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.54%
Moleculin Biotech: Aktie bricht nach Vereinbarung zur Optionsscheinausübung ein
Moleculin Biotech stock plunges after warrant exercise agreement
Moleculin Biotech sichert sich 8,3 Millionen US-Dollar durch Ausübung von Optionsscheinen
Moleculin Biotech raises $8.3 million through warrant exercise
Moleculin Biotech: Aktie legt nach vielversprechenden Studiendaten zu AML-Medikament zu
Moleculin Biotech stock rises as AML drug trial shows promising results
Moleculin: Positive erste Daten aus zulassungsrelevanter Studie zur AML-Behandlung
Moleculin reports promising early data in pivotal AML treatment trial
Moleculin Biotech: Aktie legt nach wichtiger Patenterteilung in Japan zu
Moleculin Biotech stock rises after securing key Japanese patent